Previous reports of radiation in mouse models of pancreatic cancer revealed an increase in immunosuppressive monocytes recruited by CCL2, and combination therapy modestly increased the frequency of tumour-infiltrating monocytes (figure 2f) [47]. The gene discussed is CCL2; the disease is neoplasm.